The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis
Open accessThe DOI matches its Crossref record; 69 of the 70 references it cites were found in a registry or an index.
Abstract
CXCL13 is a key B cell chemoattractant and marker of disease activity in patients with SLE; however, the mechanism of its induction has not been identified yet. Here, we have shown that the proteoglycan biglycan triggers CXCL13 expression via TLR2/4 in macrophages and dendritic cells. In vivo, levels of biglycan were markedly elevated in the plasma and kidneys of human SLE patients and lupus-prone (MRL/lpr) mice. Overexpression of soluble biglycan in MRL/lpr mice raised plasma and renal levels of CXCL13 and caused accumulation of B cells with an enhanced B1/B cell ratio in the kidney, worsening of organ damage, and albuminuria. Importantly, biglycan also triggered CXCL13 expression and B cell infiltration in the healthy kidney. Conversely, biglycan deficiency improved systemic and renal outcome in lupus-prone mice, with lower levels of autoantibodies, less enlargement of the spleen and lymph nodes, and reduction in renal damage and albuminuria. This correlated with a marked decline in circulating and renal CXCL13 and a reduction in the number of B cells in the kidney. Collectively, our results describe what we believe to be a novel mechanism for the regulation of CXCL13 by biglycan, a host-derived ligand for TLR2/4. Blocking biglycan-TLR2/4 interactions might be a promising strategy for the management of SLE and other B cell-mediated inflammatory disease entities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Innate immune cells also recognize glycans released from tissue damage in vertebrates such as hyaluronan fragments (467, 914 -915) and some matrix proteoglycans (956 -957) as danger-associated molecular patterns (DAMPs) or ' alarmins ' , triggering responses similar to those generated by exogenous PAMPs”
From Biological roles of glycans (2017) · cites this paper as [956]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
Lawrence, R. C., Felson, D. T., Helmick, C. G., Arnold, L. M., Choi, H., Deyo, R. A., Gabriel, S., Hirsch, R., Hochberg, M. C., Hunder, G. G., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23176 · Cited by 5,499
Derivation of the sledai. A disease activity index for lupus patients
Bombardier, C., Gladman, D. D., Urowitz, M. B., Caron, D., Chang, C. H., Austin, A., Bell, A., Bloch, D. A., Corey, P. N., Decker, J. L., et al. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350606 · Cited by 4,570
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I
Helmick, C. G., Felson, D. T., Lawrence, R. C., Gabriel, S., Hirsch, R., Kwoh, C. K., Liang, M. H., Kremers, H. M., Mayes, M. D., Merkel, P. A., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23177 · Cited by 2,058
Rahman, A., & Isenberg, D. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmra071297 · Cited by 1,632
Förster, R., Mattis, A. E., Kremmer, E., Wolf, E., Brem, G., & Lipp, M. (1996) · Cell · doi:10.1016/s0092-8674(00)81798-5 · Cited by 1,129
Rahman, M. U. (2008) · Essentials of Physical Medicine and Rehabilitation · doi:10.1016/b978-1-4160-4007-1.50153-x · Cited by 1,019
Martin, F., Oliver, A. M., & Kearney, J. F. (2001) · Immunity · doi:10.1016/s1074-7613(01)00129-7 · Cited by 985
Schaefer, L., Babelova, A., Kiss, E., Hausser, H.-J., Baliova, M., Krzyzankova, M., Marsche, G., Young, M. F., Mihalik, D., Götte, M., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23755 · Cited by 850
Self-citationTLR4 activation mediates kidney ischemia/reperfusion injury
Wu, H., Chen, G., Wyburn, K. R., Yin, J., Bertolino, P., Eris, J. M., Alexander, S. I., Sharland, A. F., & Chadban, S. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31008 · Cited by 836
A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1
Gunn, M. D., Ngo, V. N., Ansel, K. M., Ekland, E. H., Cyster, J. G., & Williams, L. T. (1998) · Nature · doi:10.1038/35876 · Cited by 835
Schned, E. S., Glickstein, S. L., & Anne Doyle, M. T. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360623 · Cited by 725
Austin, H. A., Muenz, L. R., Joyce, K. M., Antonovych, T. T., & Balow, J. E. (1984) · Kidney International · doi:10.1038/ki.1984.75 · Cited by 718
Haas, K. M., Poe, J. C., Steeber, D. A., & Tedder, T. F. (2005) · Immunity · doi:10.1016/j.immuni.2005.04.011 · Cited by 628
Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice
Xu, T., Bianco, P., Fisher, L. W., Longenecker, G., Smith, E., Goldstein, S., Bonadio, J., Boskey, A., Heegaard, A.-M., Sommer, B., et al. (1998) · Nature Genetics · doi:10.1038/1746 · Cited by 612
Self-citationHerzenberg, L. A., Stall, A. M., Lalor, P. A., Sidman, C., Moore, W. A., Parks, D. R., & Herzenberg, L. A. (1986) · Immunological Reviews · doi:10.1111/j.1600-065x.1986.tb01503.x · Cited by 593
Gordon, C., Li, C. K., & Isenberg, D. A. (2010) · Medicine · doi:10.1016/j.mpmed.2009.10.006 · Cited by 565
Biological Functions of the Small Leucine-rich Proteoglycans: From Genetics to Signal Transduction
Schaefer, L., & Iozzo, R. V. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800020200 · Cited by 549
Self-citationProteoglycans: from structural compounds to signaling molecules
Schaefer, L., & Schaefer, R. M. (2010) · Cell and Tissue Research · doi:10.1007/s00441-009-0821-y · Cited by 548
Self-citationKerjaschki, D., Regele, H. M., Moosberger, I., Nagy-Bojarski, K., Watschinger, B., Soleiman, A., Birner, P., Krieger, S., Hovorka, A., Silberhumer, G., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000113316.52371.2e · Cited by 480
Biglycan, a Danger Signal That Activates the NLRP3 Inflammasome via Toll-like and P2X Receptors
Babelova, A., Moreth, K., Tsalastra-Greul, W., Zeng-Brouwers, J., Eickelberg, O., Young, M. F., Bruckner, P., Pfeilschifter, J., Schaefer, R. M., Gröne, H.-J., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014266 · Cited by 474
Self-citationMediators of Diabetic Renal Disease: The Case for TGF-β as the Major Mediator
Ziyadeh, F. N. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000093460.24823.5b · Cited by 463
Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse.
Shlomchik, M. J., Aucoin, A. H., Pisetsky, D. S., & Weigert, M. G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9150 · Cited by 462
Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins
Fisher, L. W., Stubbs, J. T., & Young, M. F. (1995) · Acta Orthopaedica Scandinavica · doi:10.3109/17453679509157649 · Cited by 443
Self-citationB1b Lymphocytes Confer T Cell-Independent Long-Lasting Immunity
Alugupalli, K. R., Leong, J. M., Woodland, R. T., Muramatsu, M., Honjo, T., & Gerstein, R. M. (2004) · Immunity · doi:10.1016/j.immuni.2004.06.019 · Cited by 411
Marshak-Rothstein, A., & Rifkin, I. R. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104514 · Cited by 389
Transforming growth factor-β regulates production of proteoglycans by mesangial cells
Border, W. A., Okuda, S., Languino, L. R., & Ruoslahti, E. (1990) · Kidney International · doi:10.1038/ki.1990.35 · Cited by 363
van de Pavert, S. A., Olivier, B. J., Goverse, G., Vondenhoff, M. F., Greuter, M., Beke, P., Kusser, K., Höpken, U. E., Lipp, M., Niederreither, K., et al. (2009) · Nature Immunology · doi:10.1038/ni.1789 · Cited by 312
Regulation of B1 cell migration by signals through Toll-like receptors
Ha, S.-A., Tsuji, M., Suzuki, K., Meek, B., Yasuda, N., Kaisho, T., & Fagarasan, S. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061041 · Cited by 290
Chemokines and chemokine receptors are involved in the resolution or progression of renal disease
Anders, H.-J., Vielhauer, V., & Schlöndorff, D. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00750.x · Cited by 270
B-1 cells: the lineage question revisited
Herzenberg, L. A. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.017520.x · Cited by 245
LEMA, G. P. D., MAIER, H., NIETO, E., VIELHAUER, V., LUCKOW, B., MAMPASO, F., & SCHLO[Combining Diaeresis]NDORFF, D. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1271369 · Cited by 243
Activated Renal Macrophages Are Markers of Disease Onset and Disease Remission in Lupus Nephritis
Schiffer, L., Bethunaickan, R., Ramanujam, M., Huang, W., Schiffer, M., Tao, H., Madaio, M. M., Bottinger, E. P., & Davidson, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1938 · Cited by 228
The matricellular functions of small leucine-rich proteoglycans (SLRPs)
Merline, R., Schaefer, R. M., & Schaefer, L. (2009) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-009-0066-2 · Cited by 200
Self-citationKomatsuda, A., Wakui, H., Iwamoto, K., Ozawa, M., Togashi, M., Masai, R., Maki, N., Hatakeyama, T., & Sawada, K. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03646.x · Cited by 173
Schaefer, L., Macakova, K., Raslik, I., Micegova, M., Gröne, H.-J., Schönherr, E., Robenek, H., Echtermeyer, F. G., Grässel, S., Bruckner, P., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64937-1 · Cited by 160
Self-citationIshikawa, S., Sato, T., Abe, M., Nagai, S., Onai, N., Yoneyama, H., Zhang, Y.-Y., Suzuki, T., Hashimoto, S.-I., Shirai, T., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.12.1393 · Cited by 152
Analysis and classification of B-cell infiltrates in lupus and ANCA-associated nephritis
Steinmetz, O. M., Velden, J., Kneissler, U., Marx, M., Klein, A., Helmchen, U. M., Stahl, R. A. K., & Panzer, U. (2008) · Kidney International · doi:10.1038/ki.2008.191 · Cited by 144
Wahab, N. A., Schaefer, L., Weston, B. S., Yiannikouris, O., Wright, A., Bábelová, A., Schaefer, R. M., & Mason, R. M. (2005) · Diabetologia · doi:10.1007/s00125-005-0006-5 · Cited by 139
Self-citationTLR4 Up-Regulation at Protein or Gene Level Is Pathogenic for Lupus-Like Autoimmune Disease
Liu, B., Yang, Y., Dai, J., Medzhitov, R., Freudenberg, M. A., Zhang, P. L., & Li, Z. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.6880 · Cited by 139
Schaefer, L., Raslik, I., Gröne, H., Schönherr, E., Macakova, K., Ugorcakova, J., Budny, S., Schaefer, R. M., & Kresse, H. (2001) · The FASEB Journal · doi:10.1096/fj.00-0493fje · Cited by 138
Self-citationThe Contribution of B Cells to Renal Interstitial Inflammation
Heller, F., Lindenmeyer, M. T., Cohen, C. D., Brandt, U., Draganovici, D., Fischereder, M., Kretzler, M., Anders, H., Sitter, T., Mosberger, I., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060554 · Cited by 136
MOZES, M. M., BÖTTINGER, E. P., JACOT, T. A., & KOPP, J. B. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v102271 · Cited by 127
The Role of Toll-Like Receptor 2 in Inflammation and Fibrosis during Progressive Renal Injury
Leemans, J. C., Butter, L. M., Pulskens, W. P. C., Teske, G. J. D., Claessen, N., van der Poll, T., & Florquin, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005704 · Cited by 118
Perrier, P., Martinez, F. O., Locati, M., Bianchi, G., Nebuloni, M., Vago, G., Bazzoni, F., Sozzani, S., Allavena, P., & Mantovani, A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.7031 · Cited by 110
Schaefer, L., Gröne, H., Raslik, I., Robenek, H., Ugorcakova, J., Budny, S., Schaefer, R. M., & Kresse, H. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00317.x · Cited by 110
Self-citationMonfort, J., Tardif, G., Reboul, P., Mineau, F., Roughley, P., Pelletier, J.-P., & Martel-Pelletier, J. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1873 · Cited by 107
The role of innate immunity in autoimmune tissue injury
Allam, R., & Anders, H. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283025ed4 · Cited by 104
NZB/NZW mice as a model of systemic lupus erythematosus.
Dubois, E. L., Horowitz, R. E., Demopoulos, H. B., & Teplitz, R. L. (1966) · PubMed · Cited by 103
Toll-Like Receptors and Renal Disease
Robson, M. G. (2009) · Nephron Experimental Nephrology · doi:10.1159/000228077 · Cited by 94
Borrelia gariniiInduces CXCL13 Production in Human Monocytes through Toll-Like Receptor 2
Rupprecht, T. A., Kirschning, C. J., Popp, B., Kastenbauer, S., Fingerle, V., Pfister, H., & Koedel, U. (2007) · Infection and Immunity · doi:10.1128/iai.01642-06 · Cited by 94
B cells and tertiary lymphoid organs in renal inflammation
Segerer, S., & Schlöndorff, D. (2007) · Kidney International · doi:10.1038/sj.ki.5002734 · Cited by 85
Extracellular matrix molecules: endogenous danger signals as new drug targets in kidney diseases
Schaefer, L. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.11.007 · Cited by 84
Self-citationLim, A. K. H., Ma, F. Y., Nikolic‐Paterson, D. J., Kitching, A. R., Thomas, M. C., & Tesch, G. H. (2010) · Diabetologia · doi:10.1007/s00125-010-1757-1 · Cited by 82
Schiffer, L. E., Kumpers, P., Davalos‐Misslitz, A. C. M., Haubitz, M., Haller, H. G., Anders, H., Witte, T., & Schiffer, M. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp343 · Cited by 77
Steinmetz, O. M., Panzer, U., Kneissler, U., Harendza, S., Lipp, M., Helmchen, U. M., & Stahl, R. A. K. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00244.x · Cited by 74
Transcriptional Regulation of the Human Biglycan Gene
Ungefroren, H., & Krull, N. B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15787 · Cited by 73
Ito, T., Ishikawa, S., Sato, T., Akadegawa, K., Yurino, H., Kitabatake, M., Hontsu, S., Ezaki, T., Kimura, H., & Matsushima, K. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3628 · Cited by 72
Biglycan, a Nitric Oxide-regulated Gene, Affects Adhesion, Growth, and Survival of Mesangial Cells
Schaefer, L., Beck, K., Raslik, I., Walpen, S., Mihálik, D., Micegova, M., Mačáková, K., Schönherr, E., Seidler, D. G., Varga, G., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210574200 · Cited by 66
Self-citationKidney Diseases and Chemokines
Panzer, U., Steinmetz, O. M., Stahl, R. A. K., & Wolf, G. (2006) · Current Drug Targets · doi:10.2174/138945006775270213 · Cited by 57
Kulkarni, O. P. (2008) · Frontiers in bioscience · doi:10.2741/2927 · Cited by 52
Suto, H., Katakai, T., Sugai, M., Kinashi, T., & Shimizu, A. (2009) · International Immunology · doi:10.1093/intimm/dxp014 · Cited by 48
Yamamoto, K., & Loskutoff, D. J. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780166 · Cited by 43
Tucci, M., Ciavarella, S., Strippoli, S., Dammacco, F., & Silvestris, F. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04805.x · Cited by 37
Ferraccioli, G., & Romano, G. (2008) · Lupus · doi:10.1177/0961203307088002 · Cited by 37
Qin, J., Konno, H., Ohshima, D., Yanai, H., Motegi, H., Shimo, Y., Hirota, F., Matsumoto, M., Takaki, S., Inoue, J., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.10.6799 · Cited by 24
NZB/NZW mice as a model of systemic lupus erythematosus
Dubois, E. L. (1966) · JAMA · doi:10.1001/jama.195.4.285 · Cited by 11
Hojgaard, A., Close, R., Dunn, D. M., Weiss, R. B., Weis, J. J., & Weis, J. H. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02426.x · Cited by 10
Formation of lymphoid-like tissue in the kidney--is there a role for chemokines?
Steinmetz, O. M., Stahl, R. A. K., & Panzer, U. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl679 · Cited by 8
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“(956, 957) as DAMPs or "alarmins", triggering responses similar to those generated by exogenous PAMPs”
BackgroundComplexity of Danger: The Diverse Nature of Damage-associated Molecular Patterns
Schaefer, L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.619304 · Cited by 622
Self-citationZhu, S., Pan, W., Song, X., Liu, Y., Shao, X., Tang, Y., Liang, D., He, D., Wang, H., Liu, W., et al. (2012) · Nature Medicine · doi:10.1038/nm.2815 · Cited by 396
TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review
Liu, Y., Yin, H., Zhao, M., & Lu, Q. (2014) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-013-8402-y · Cited by 365
“Conversely, activation of TLR2/4 by proteoglycan biglycanin MRL/lpr mice can trigger CXCL13 expression and cause accumulation of B cells with an enhanced B1/B cell ratio in the kidney [80].”
BackgroundMerline, R., Moreth, K., Beckmann, J., Nastase, M. V., Zeng-Brouwers, J., Tralhão, J. G., Lemarchand, P., Pfeilschifter, J., Schaefer, R. M., Iozzo, R. V., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001868 · Cited by 333
“Like decorin, the small leucine-rich proteoglycan biglycan also signals through both TLR2 and TLR4 (29), thereby regulating pathogen-mediated and sterile inflammation (29, 35) and mediating both innate and adaptive immune responses (36).”
BackgroundMethodInfluentialSelf-citation
Metadata
- Authors
- Moreth, K., Brodbeck, R., Babelova, A., Gretz, N., Spieker, T., Zeng-Brouwers, J., Pfeilschifter, J., Young, M. F., Schaefer, R. M., & Schaefer, L.
- Affiliations
- Goethe University Frankfurt (DE)
- Heidelberg University (DE)
- University of Münster (DE)
- National Institutes of Health (US)
- Corresponding author
- Schaefer, Liliana
- Venue
- Journal of Clinical Investigation
- Published
- 2010-12-01
- Volume
- 120
- Issue
- 12
- Pages
- 4251-4272
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2993585
- OpenAlex
- W1968712129
- Cited by
- 207
- References
- 70
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 10 · 2023: 11 · 2022: 20 · 2021: 22 · 2020: 13 · 2019: 15 · 2018: 8 · 2017: 12 · 2016: 8 · 2015: 18 · 2014: 15 · 2013: 14 · 2012: 18
- FWCI
- 9.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (GRK1172, Project A7, SFB 815, project A5)
- Else Kröner-Fresenius-Stiftung
- Goethe-Universität Frankfurt am Main
- National Institutes of Health (SFB 815)
- National Institute of Dental and Craniofacial Research
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
- Keywords
- biglycan, CXCL13, systemic lupus erythematosus, lupus nephritis, TLR2/4 signaling, proteoglycans, macrophages, dendritic cells, MRL/lpr mice, albuminuria, autoantibodies
- MeSH terms
- Adolescent, Adult, Animals, B-Lymphocytes, Diabetic Nephropathies, Female, Graft Rejection, Humans, Kidney, Lupus Erythematosus, Systemic, Lupus Nephritis, Macrophages, Male, Mice, Inbred C57BL, Mice, Inbred NZB, T-Lymphocytes, Case-Control Studies, Cytokines, Mice, Knockout, Chemokines, Mice, Inbred MRL lpr, Toll-Like Receptor 2, Toll-Like Receptor 4, Mice, Chemokine CXCL13, Young Adult, Biglycan
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.